Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck adds regulatory unit to its research operations

Appoints Jens Peter Balling to lead the product support, patient safety and quality assurance unit

Danish pharma company Lundbeck has set up a new unit within its research operations to focus on regulatory product support, patient safety and quality assurance of clinical research.

It will be led by Jens Peter Balling, who has been appointed vice president of regulatory affairs, pharmacovigilance and clinical quality assurance within the company's R&D operations.

Balling has been with Lundbeck since 2006, when he joined as divisional director of global pharmacovigilance, and previously worked for Novo Nordisk and Nycomed.

He will be joined in the new unit by Iman Barilero, also newly appointed as vice president of regulatory development strategy and policy and who has a liaison role with regulatory authorities.

Anders Gersel Pedersen, Lundbeck's executive vice president of research and development, said: "The appointments of Jens Peter Balling and Iman Barilero reflect our efforts to build a strong and competent research and development organisation that enables us to continue to deliver results as we invest in the future. The regulatory and safety areas are an increasingly important prerequisite for this.

“The creation of one new unit and the increased focus on the other gives us a strong position in these areas.”

8th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics